Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Feb-20 6:41 PM View:  | Dexcel Pharma Technologies ... 10% Owner | Intec Pharma Ltd. (NTEC) | 04-Feb-20 | Market Sale | 110,000 | $0.29 | $31,900.00 | (3%) 4.34M to 4.23M | 54% |
| 04-Feb-20 6:41 PM View: | Dexcel Pharma Technologies ... 10% Owner | Intec Pharma Ltd. (NTEC) | 03-Feb-20 | Market Sale | 80,000 | $0.32 | $25,440.00 | (2%) 4.42M to 4.34M | 60% |
| 04-Feb-20 6:41 PM View: | Dexcel Pharma Technologies ... 10% Owner | Intec Pharma Ltd. (NTEC) | 31-Jan-20 | Market Sale | 725,951 | $0.31 | $224,319.00 | (14%) 5.15M to 4.42M | 58% |
| 21-Nov-19 5:00 PM View: | Silberman Issac Director | Intec Pharma Ltd. (NTEC) | 19-Nov-19 | Market Sale | 1,000 | $0.50 | $504.00 | 33% 3.0K to 4.0K | (74%) |
| 29-Aug-19 4:16 PM View: | Meckler Jeffrey A Chief Executive Officer Director | Intec Pharma Ltd. (NTEC) | 28-Aug-19 | Market Purchase | 20,000 | $0.68 | $13,620.00 | 11% 176.76K to 196.76K | (80%) |
| 29-Aug-19 4:16 PM View: | Maddaluna Anthony J Director | Intec Pharma Ltd. (NTEC) | 27-Aug-19 | Market Purchase | 25,000 | $0.47 | $11,750.00 | 88% 28.57K to 53.57K | (71%) |
| 27-Aug-19 4:18 PM View: | Meckler Jeffrey A Chief Executive Officer Director | Intec Pharma Ltd. (NTEC) | 23-Aug-19 | Market Purchase | 100,000 | $0.46 | $45,700.00 | 130% 76.76K to 176.76K | (70%) |
| 27-Aug-19 4:20 PM View: | Kozarich John W Director | Intec Pharma Ltd. (NTEC) | 23-Aug-19 | Market Purchase | 100,000 | $0.46 | $45,900.00 | 193% 51.76K to 151.76K | (70%) |
